Chugai Pharmaceutical Co., Ltd. (CHGCY)
OTCMKTS · Delayed Price · Currency is USD
22.19
+0.04 (0.16%)
Oct 30, 2025, 11:42 AM EDT
Chugai Pharmaceutical Revenue
Chugai Pharmaceutical had revenue of 333.18B JPY in the quarter ending September 30, 2025, with 5.54% growth. This brings the company's revenue in the last twelve months to 1.21T, up 6.25% year-over-year. In the year 2024, Chugai Pharmaceutical had annual revenue of 1.17T with 5.33% growth.
Revenue (ttm)
1.21T JPY
Revenue Growth
+6.25%
P/S Ratio
8.98
Revenue / Employee
241.49M JPY
Employees
5,026
Market Cap
73.69B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.17T | 59.24B | 5.33% |
| Dec 31, 2023 | 1.11T | -148.58B | -11.79% |
| Dec 31, 2022 | 1.26T | 260.19B | 26.02% |
| Dec 31, 2021 | 999.76B | 212.81B | 27.04% |
| Dec 31, 2020 | 786.95B | 100.76B | 14.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |
Chugai Pharmaceutical News
- 6 days ago - Chugai Pharmaceutical 9-month Net Income Rises - Nasdaq
- 10 days ago - Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Benzinga
- 13 days ago - Rani Therapeutics surges on Chugai licensing deal, private placement - Seeking Alpha
- 13 days ago - Rani Teams Up With Chugai To Revolutionize Oral Drug Delivery For Rare Diseases - Benzinga
- 3 months ago - Chugai Pharmaceutical Co., Ltd. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - Chugai Pharmaceutical Co., Ltd. (CHGCF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Chugai Pharmaceutical reports Q2 results - Seeking Alpha
- 5 months ago - Biotech behind Eli Lilly obesity pill aims for new standard of care - Financial Times